These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 154317)

  • 21. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan.
    Stevens CE; Neurath RA; Beasley RP; Szmuness W
    J Med Virol; 1979; 3(3):237-41. PubMed ID: 479860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B e antigen and antibody activity in hepatitis B virus infection.
    Tiku ML; Makhdoomi GM; Beutner KR; Nath N; Ogra PL
    J Pediatr; 1977 Oct; 91(4):540-4. PubMed ID: 908972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigations of HBe antigen. Note I. Prevalence of HBeAg and anti-HBe in the stationary phase of HBsAg-positive acute viral hepatitis.
    Babeş VT; Tănase M; Cepănaru S; Cepănaru R
    Virologie; 1981; 32(2):93-8. PubMed ID: 6787796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of hepatitis B E antigens, anti-hepatitis B E and Dane particles in the serum of hepatitis B S carriers and patients with chronic hepatitis B S antigen-positive hepatitis].
    Reichlin B; Stalder GA; Gudat F; Bianchi L; Froesner GG
    Schweiz Med Wochenschr; 1982 Apr; 112(15):523-4. PubMed ID: 7079688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of HBe antigen in sera from HBs antigen asymptomatic carrier and hepatitis patients using polyethylene glycol (PEG).
    Tsuji T; Okada T; Nagashima H
    Gastroenterol Jpn; 1979; 14(3):206-10. PubMed ID: 109343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of HBeAg and anti-HBe in blood donors with HBs antigenemia.
    Sabău M; Demeter S
    Virologie; 1978; 29(3):209-12. PubMed ID: 99868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H; Kurimura O; Tamura I; Shimase K; Kaneto E; Kurimura T; Tsuda F; Mayumi M
    Biken J; 1984 Dec; 27(4):169-76. PubMed ID: 6100353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of HBe/anti-HBe system and DNA polymerase activity in chronic hepatitis-B virus carriers on haemodialysis. A prospective study.
    Marchesini G; Zoli M; Angiolini A; Feliciangeli G; Santoro A; Ferroni P; Zanetti AR
    Nephron; 1981; 29(1-2):44-8. PubMed ID: 7329473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma.
    Alward WL; McMahon BJ; Hall DB; Heyward WL; Francis DP; Bender TR
    J Infect Dis; 1985 Apr; 151(4):604-9. PubMed ID: 2982971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence of serological markers, hepatitis B virus DNA and elevated serum amino transferase values in institutionalized mentally handicapped males and females: an epidemiological study of HBV infection in residents with Down's syndrome or other forms of mental deficiency.
    van Ditzhuijsen TJ; Kleijnen FM; Rijntjes PJ; van Loon AM; Yap SH
    Eur J Epidemiol; 1988 Sep; 4(3):349-56. PubMed ID: 2972557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT; Cepănaru S; Cepănaru R; Tănase M
    Virologie; 1981; 32(3):187-91. PubMed ID: 7303492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of hepatitis B virus in an institution for mentally retarded persons.
    Madden DL; Dietzman DE; Matthew EB; Sever JL; Lander JJ; Purcell RH; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):369-75. PubMed ID: 129004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 34. [Occurrence of hepatitis B and C among mentally retarded].
    Lunding S; Hansen KS; Krogsgaard K; Rosdahl N; Smith E; Wantzin PS
    Ugeskr Laeger; 1999 Aug; 161(31):4393-6. PubMed ID: 10487103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis B virus antigens and antibodies in acute infection].
    Ketiladze ES; Zhilina NN; Vorozhbieva TE; Goldberg EZ; Farber NA
    Vopr Virusol; 1980; (2):232-6. PubMed ID: 7385794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large-scale survey on the prevalence of HBeAG and anti-HBe among asymptomatic carriers of HBV. Correlation with sex, age, HBsAG titre and s-GPT value.
    Sasaki T; Hattori T; Mayumi M
    Vox Sang; 1979; 37(4):216-21. PubMed ID: 494592
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis and Down's syndrome.
    Madden DL; Matthew EB; Dietzman DE; Purcell RH; Sever JL; Rostafinski M; Mata A
    Am J Ment Defic; 1976 Jan; 80(4):401-6. PubMed ID: 129005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS; Sung JL; Lai MY
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [e/Anti-e system in liver disease].
    Resta ML; Freni MA; Berlinghieri G; Ajello A; Crinò M; Ferraù O
    Boll Soc Ital Biol Sper; 1980 Oct; 56(20):2123-8. PubMed ID: 7459125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HBeAg/anti-HBe system in the acute phase of HBsAg-positive hepatitis as a predictive test of developing chronic hepatitis.
    Caredda F; D'Arminio Monforte A; Rossi E; Cultraro D; Marescotti C; Moroni M
    Boll Ist Sieroter Milan; 1981; 60(6):468-79. PubMed ID: 7344717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.